Citalopram

Indications & formulation #

Major depressive disorder in adults. This reference covers the selected formulation; other indications and products need their own evidence.

Dose reference #

Adult educational reference · Oral tablet · United States. The clinician selects treatment after assessment; this page does not calculate or change a prescription.

Start 20 mg/day; increase no sooner than one week if appropriate. Maximum 40 mg/day because of QT effects.

Contraindications & important cautions #

Avoid MAOIs and pimozide. Review QT prolongation, electrolyte abnormalities and other QT-prolonging medicines.

Selected important cautions; consult the full product information for all contraindications and warnings.

Adverse effects #

Dose/exposure-related QT prolongation is an important prescribing consideration, alongside typical SSRI adverse effects.

Interactions #

Review QT-prolonging combinations, metabolic inhibitors, serotonergic agents and electrolyte disturbance.

Monitoring #

Use the selected label’s age-, organ-function- and interaction-specific limits. Assess ECG and electrolytes where indicated.

Special populations #

Maximum 20 mg/day in people over 60, hepatic impairment, CYP2C19 poor metabolizers or with CYP2C19 inhibitors.

Adult scope. Pregnancy, breastfeeding and pediatric use require the exact product’s population-specific guidance and individual assessment.

Discontinuation, restarting & counseling #

Taper gradually; distinguish withdrawal from depressive relapse.

Brands & products #

Reference coverage #

Structured summary of selected adult uses, not an exhaustive monograph. Indian product authorization and local prescribing requirements have not been reconciled.